Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance?

International Journal of Antimicrobial Agents

Volumn 29, Issue SUPPL. 1, 2007, Pages

  Marchese, Anna ^a   Schito, Gian Carlo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antibiotic resistance; Ketolide; Penicillin resistance; Respiratory tract infection; Streptococcus pneumoniae; Telithromycin

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAMASE; CEFDINIR; CEPHALOSPORIN; CLAVULANIC ACID; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; SULBACTAM; TELITHROMYCIN;

ACUTE SINUSITIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHRONIC BRONCHITIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG SENSITIVITY; HAEMOPHILUS INFLUENZAE; MULTIDRUG RESISTANCE; NONHUMAN; OTITIS MEDIA; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 33847272222     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(07)70003-1     Document Type: Article

References (18)

1. Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother 50 Suppl S1 (2002) 1-7
2. Felmingham D., Feldman C., Hryniewicz W., et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect 8 Suppl 2 (2002) 12-42
3. Farrell D., Canton R., and Hryniewicz W. Trends in antibacterial resistance of Streptococcus pneumoniae: PROTEKT global years 1-5. Clin Microbiol Infect 12 Suppl 4 (2006) P1279
4. Schito G., Farrell D., and Ramirez J. Activity of telithromycin against Streptococcus pneumoniae isolates resistant to other antibacterials: PROTEKT year 5. Clin Microbiol Infect 12 Suppl 4 (2006) P1280
5. File Jr. T., Garau J., Blasi F., et al. Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 125 (2004) 1888-1901
6. Marchese A., Gualco L., Cochetti I., et al. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents 26 (2005) 138-145
7. Marchese A., Ardito F., Fadda G., et al. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy. Int J Antimicrob Agents 26 (2005) 8-12
8. Jacobs M., Felmingham D., Appelbaum P., and Gruneberg R. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 52 (2003) 229-246
9. Felmingham D., Reinert R., Hirakata Y., and Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 50 Suppl S1 (2002) 25-37
10. Farrell D., Morrissey I., Bakker S., and Felmingham D. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother 50 Suppl S1 (2002) 39-47
11. Farrell D., Morrissey I., Bakker S., Morris L., Buckridge S., and Felm-ingham D. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef (A)-mediated macrolide resistance. J Clin Microbiol 42 (2004) 764-768
12. Schito G., Marchese A., Elkharrat D., and Farrell D. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study. J Chemother 16 (2004) 13-22
13. Farrell D., and Felmingham D. The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae. J Antimicrob Chemother 56 (2005) 795-797
14. Farrell D., Jenkins S., Brown S., Patel M., Lavin B., and Klugman K. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef (A) resistance. Emerg Infect Dis 11 (2005) 851-858
15. Felmingham D., and Gruneberg R. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45 (2000) 191-203
16. Heilmann K., Rice C., Miller A., et al. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother 49 (2005) 2561-2564
17. Dabernat H., Delmas C., Seguy M., et al. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46 (2002) 2208-2218
18. Sunakawa K., and Farrell D. Prevalence of antibacterial resistance among pediatric isolates of Haemophilus influenzae (HI) and activity of telithromycin (TEL) in Japan. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C. USA (October 30-November 2, 2004) C2-C806